The U.S. Food and Drug Administration announced Wednesday a request for all manufacturers to withdraw all prescription and over-the-counter ranitidine drugs from the market immediately, including the ...
The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...
WASHINGTON -- U.S. health officials said Friday they are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related generic drugs. For now, ...
CVS Pharmacy has suspended the sale of Zantac and other ranitidine products at its drugstores after the FDA flagged a possible human carcinogen in the popular heartburn drugs. In a Sept. 28 statement, ...
After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...
Another recall of prescription-strength ranitidine (over-the-counter brand name: Zantac) for possibly having too much of the carcinogen NDMA is distinguished by Walmart taking care to post an ...
Dechert to Defend GSK in Securities Class Action Over Alleged Link Between Zantac and Carcinogenic Compound This action was surfaced by Law.com Radar, which delivers real-time alerting on new ...
The FDA said an outside lab that reported very high levels of a carcinogen in ranitidine products used an “unsuitable” testing method, causing misleading results. In a statement released Oct. 2, the ...
The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback